Filing Details
- Accession Number:
- 0001703039-19-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-04 16:52:51
- Reporting Period:
- 2019-02-28
- Accepted Time:
- 2019-03-04 16:52:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
874866 | Corvel Corp | CRVL | Insurance Agents, Brokers & Service (6411) | 330282651 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1703039 | Maxim Shishin | 2010 Main Street Suite 600 Irvine CA 92614 | Chief Information Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-02-28 | 400 | $35.77 | 400 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-02-28 | 400 | $66.53 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2019-02-28 | 750 | $34.78 | 750 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-02-28 | 750 | $66.53 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-02-28 | 750 | $0.00 | 750 | $34.78 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-02-28 | 400 | $0.00 | 400 | $35.77 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2019-11-10 | No | 4 | M | Direct | |
0 | 2020-02-05 | No | 4 | M | Direct |
Footnotes
- Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter.